GlobeImmune Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure28.8yrs
Board average tenure20.5yrs

Recent management updates

No updates

Recent updates

No updates


CEO

GlobeImmune has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
C. Dekker
President13.1yrsUS$269.50kno data
Richard Duke
Scientific Founder & Member of Scientific Advisory Board28.8yrsno datano data
Donald Bellgrau
Scientific Founder & Chairman of The Scientific Advisory Board28.8yrsno datano data

28.8yrs

Average Tenure

Experienced Management: GBIM's management team is seasoned and experienced (28.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Richard Duke
Scientific Founder & Member of Scientific Advisory Boardno datano datano data
Donald Bellgrau
Scientific Founder & Chairman of The Scientific Advisory Boardno datano datano data
Timothy Rodell
Director21.6yrsUS$637.95kno data
Robert Schooley
Member of Scientific Advisory Boardno datano datano data
Paul A. Bunn
Member of Scientific Advisory Boardno datano datano data
Carl June
Member of Scientific Advisory Boardno datano datano data
Alan Venook
Member of Scientific Advisory Boardno datano datano data
Bruce Walker
Member of Scientific Advisory Boardno datano datano data
Francis Chisari
Member of Scientific Advisory Board19.3yrsno datano data
Teresa Brentnall
Member of Scientific Advisory Board20.5yrsno datano data
Edward Mocarski
Member of Scientific Advisory Board20.5yrsno datano data
Robert Peach
Member of Scientific Advisory Board18.3yrsno datano data

20.5yrs

Average Tenure

71.5yo

Average Age

Experienced Board: GBIM's board of directors are seasoned and experienced ( 20.5 years average tenure).